← Back to Search
Kinetics Of Interaction Of HIV Reverse Transcriptase With Primer/template.
G. Divita, B. Müller, U. Immendörfer, M. Gautel, K. Rittinger, T. Restle, R. Goody
Published 1993 · Chemistry, Medicine
Download PDFAnalyze on Scholarcy
Intrinsic protein fluorescence of reverse transcriptases from HIV-1 and HIV-2 provides a sensitive signal for monitoring the interaction of the enzymes with primer/template duplex molecules. Kd values for 18/36-mer DNA/DNA duplexes were found to be in the range of a few nanomolar (about 3 times higher for the enzyme from HIV-2 than for that from HIV-1). The quenching of protein fluorescence induced on binding primer/template, together with an increase in extrinsic fluorescence on interaction with primer/template containing a fluorescent nucleotide at the 3'-end of the primer, was used to investigate the kinetics of interaction with reverse transcriptase from HIV-1. The results can be explained in terms of a two-step binding model, with a rapid diffusion-limited initial association (k(ass) = ca. 5 x 10(8) M-1 s-1) followed by a slow isomerization step (k = ca. 0.5 s-1). These (forward) rate constants are increased in the presence of a non-nucleoside inhibitor (S-TIBO) of HIV-1 reverse transcriptase, while the reverse rate constant for the second step is decreased, leading to an increase in affinity between the enzyme and primer/template by a factor of at least 10 when S-TIBO is bound. The results are discussed in terms of present knowledge of the structure of reverse transcriptase.
This paper references
Characterization of the binding site for nevirapine (BI-RG-587), a nonnucleoside inhibitor of human immunodeficiency virus type-1 reverse transcriptase.
K. A. Cohen (1991)
Chimeric human immunodeficiency virus type 1/type 2 reverse transcriptases display reversed sensitivity to nonnucleoside analog inhibitors.
C. K. Shih (1991)
Mechanism of DNA strand transfer reactions catalyzed by HIV-1 reverse transcriptase.
J. Peliska (1992)
Co-expression of the subunits of the heterodimer of HIV-1 reverse transcriptase in Escherichia coli.
B. Müller (1989)
Interaction of fluorescently labeled dideoxynucleotides with HIV-1 reverse transcriptase.
B. Mueller (1991)
Pyridinone derivatives: specific human immunodeficiency virus type 1 reverse transcriptase inhibitors with antiviral activity.
M. Goldman (1991)
Preferential interaction of human immunodeficiency virus reverse transcriptase with two regions of primer tRNA(Lys) as evidenced by footprinting studies and inhibition with synthetic oligoribonucleotides.
L. Sarih-Cottin (1992)
Inhibition of HIV-1 replication by a nonnucleoside reverse transcriptase inhibitor.
V. Merluzzi (1990)
HIV‐1 reverse transcriptase specifically interacts with the anticodon domain of its cognate primer tRNA.
C. Barat (1989)
A novel dipyridodiazepinone inhibitor of HIV-1 reverse transcriptase acts through a nonsubstrate binding site.
J. C. Wu (1991)
Mechanism and fidelity of HIV reverse transcriptase.
W. Kati (1992)
Reverse transcriptase of human immunodeficiency virus can use either human tRNA(3Lys) or Escherichia coli tRNA(2Gln) as a primer in an in vitro primer-utilization assay.
L. A. Kohlstaedt (1992)
Synthetic human tRNA(UUULys3) and natural bovine tRNA(UUULys3) interact with HIV-1 reverse transcriptase and serve as specific primers for retroviral cDNA synthesis.
S. Weiss (1992)
A sequence motif in many polymerases.
P. Argos (1988)
Functional analysis of HIV-1 reverse transcriptase amino acids involved in resistance to multiple nonnucleoside inhibitors.
V. Sardana (1992)
Computer analysis of retroviral pol genes: assignment of enzymatic functions to specific sequences and homologies with nonviral enzymes.
M. Johnson (1986)
Human immunodeficiency virus reverse transcriptase: steady-state and pre-steady-state kinetics of nucleotide incorporation.
J. Reardon (1992)
Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivatives
R. Pauwels (1990)
Studies on the mechanism of human immunodeficiency virus reverse transcriptase. Steady-state kinetics, processivity, and polynucleotide inhibition.
C. Majumdar (1988)
Crystal structure at 3.5 A resolution of HIV-1 reverse transcriptase complexed with an inhibitor.
L. A. Kohlstaedt (1992)
Initial binding of 2'-deoxynucleoside 5'-triphosphates to human immunodeficiency virus type 1 reverse transcriptase.
G. Painter (1991)
Identification of the primer binding domain in human immunodeficiency virus reverse transcriptase.
A. Basu (1992)
Human immunodeficiency virus type 1 reverse transcriptase: spatial and temporal relationship between the polymerase and RNase H activities.
V. Gopalakrishnan (1992)
A single 66-kilodalton polypeptide processed from the human immunodeficiency virus type 2 pol polyprotein in Escherichia coli displays reverse transcriptase activity.
S. L. Le Grice (1988)
Expression of soluble, enzymatically active, human immunodeficiency virus reverse transcriptase in Escherichia coli and analysis of mutants.
A. Hizi (1988)
Kinetic interaction of human immunodeficiency virus type 1 reverse transcriptase with the antiviral tetrahydroimidazo[4,5,1-jk]-[1,4]-benzodiazepine-2-(1H)-thione compound, R82150.
K. Frank (1991)
Human immunodeficiency virus 1 reverse transcriptase. Template binding, processivity, strand displacement synthesis, and template switching.
H. Huber (1989)
AIDS virus reverse transcriptase defined by high level expression in Escherichia coli.
B. Larder (1987)
Nonnucleoside inhibitors of HIV-1 reverse transcriptase: nevirapine as a prototype drug.
P. M. Grob (1992)
Kinetics of inhibition of endogenous human immunodeficiency virus type 1 reverse transcription by 2',3'-dideoxynucleoside 5'-triphosphate, tetrahydroimidazo-[4,5,1-jk][1,4]-benzodiazepin-2(1H)-thion e, and 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine derivatives.
Z. Debyser (1992)
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.
M. M. Bradford (1976)
Expression of the heterodimeric form of human immunodeficiency virus type 2 reverse transcriptase in Escherichia coli and characterization of the enzyme.
B. Mueller (1991)
Site-specific mutagenesis of AIDS virus reverse transcriptase
B. Larder (1987)
Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia.
R. Saiki (1985)
Interaction of HIV-1 reverse transcriptase with a synthetic form of its replication primer, tRNA(Lys,3).
C. Barat (1991)
This paper is referenced by
Intrinsic tryptophan fluorescence of bovine liver adenosine kinase, characterization of ligand binding sites and conformational changes.
A. Elalaoui (1994)
Kinetic Analysis of Four HIV-1 Reverse Transcriptase Enzymes Mutated in the Primer Grip Region of p66
B. Wöhrl (1997)
HIV-1 nucleocapsid traps reverse transcriptase on nucleic acid substrates.
Dina Grohmann (2008)
Mechanism of inhibition of HIV-1 reverse transcriptase by non-nucleoside inhibitors
R. Esnouf (1995)
Human Immunodeficiency Virus Type 1 Reverse Transcriptase
M. Jaju (1995)
p66 Trp24 and Phe61 are essential for accurate association of HIV-1 reverse transcriptase with primer/template.
A. Agopian (2007)
Cystatins in health and disease.
Y. Henskens (1996)
HIV-1 Reverse Transcriptase-Pseudoknot RNA Aptamer Interaction Has a Binding Affinity in the Low Picomolar Range Coupled with High Specificity*
O. Kensch (2000)
DNA polymerase activity on synthetic N3′→P5′ phosphoramidate DNA templates
V. Lelyveld (2019)
Differential Susceptibility of HIV-1 Reverse Transcriptase to Inhibition by RNA Aptamers in Enzymatic Reactions Monitoring Specific Steps during Genome Replication*
Daniel M. Held (2006)
The interaction of HIV-1 Tat(32-72) with its target RNA: a fluorescence and nuclear magnetic resonance study.
A. Metzger (1997)
Interaction of the reverse transcriptase of human immunodeficiency virus type 1 with DNA.
M. Bakhanashvili (1994)
Impact of nonnucleoside reverse transcriptase (RT) inhibitors on the enzyme-substrate interactions and intramolecular dynamics of wild-type and drug resistant HIV-1 RT
Grant Schauer (2013)
Chemical crosslinking of the subunits of HIV‐1 reverse transcriptase
Z. Debyser (1996)
6 – DNA Polymerases
H. Eun (1996)
Site-directed mutagenesis of HIV reverse transcriptase to probe enzyme processivity and drug binding.
W. Beard (1994)
Refined Model for Primer/Template Binding by HIV-1 Reverse Transcriptase: Pre-steady-state Kinetic Analyses of Primer/Template Binding and Nucleotide Incorporation Events Distinguish Between Different Binding Modes Depending on the Nature of the Nucleic Acid Substrate
Abteilung Physikalische (1999)
Polypurine Tract Primer Generation and Utilization by Moloney Murine Leukemia Virus Reverse Transcriptase*
S. Schultz (1999)
A New Generation of Peptide-based Inhibitors Targeting HIV-1 Reverse Transcriptase Conformational Flexibility*
A. Agopian (2009)
Insights into DNA polymerization mechanisms from structure and function analysis of HIV-1 reverse transcriptase.
P. Patel (1995)
Human immunodeficiency virus‐1 reverse transcriptase heterodimer stability
J. Lebowitz (1994)
Dimerization kinetics of HIV-1 and HIV-2 reverse transcriptase: a two step process.
G. Divita (1995)
HIV-1 reverse transcriptase interaction with model RNA-DNA duplexes.
I. Gorshkova (2001)
Étude d'une nouvelle classe d'inhibiteurs de la rétrotranscriptase et de l'intégrase du virus de l'immunodéficience humaine de type-1 (VIH-1).
J. Didierjean (2005)
Role of the "Helix Clamp" in HIV-1 Reverse Transcriptase Catalytic Cycling as Revealed by Alanine-scanning Mutagenesis (*)
W. Beard (1996)
Pre-steady-state Kinetic Characterization of the DinB Homologue DNA Polymerase of Sulfolobus solfataricus*
J. Cramer (2005)
Biophysical Insights into the Inhibitory Mechanism of Non-Nucleoside HIV-1 Reverse Transcriptase Inhibitors
Grant Schauer (2013)
Synthesis of 2′,3′,5′-trideoxyuridine-5′-methylphosphonic Acid and its Diphosphate Derivative. Study of the Interaction with HIV-1 reverse Transcriptase
S. Benzaria (1994)
A new peptide vector for efficient delivery of oligonucleotides into mammalian cells.
M. Morris (1997)
Mechanisms by Which the G333D Mutation in Human Immunodeficiency Virus Type 1 Reverse Transcriptase Facilitates Dual Resistance to Zidovudine and Lamivudine
Shannon Zelina (2007)
Studies in reverse transcriptase: synthesis of inhibitors, conformational analysis, and integration of drug design
T. T. Luu (2000)
Effects of small molecular inhibitors on the binding between HIV-1 reverse transcriptase and DNA as revealed by SPR biosensor
L. Wu (2007)See more